Patent classifications
C07H15/14
POLYMERIC AMPHOTERIC SURFACTANT COMPOUND
Disclosed herein is a polymeric amphoteric surfactant compound of formula (I).
POLYMERIC AMPHOTERIC SURFACTANT COMPOUND
Disclosed herein is a polymeric amphoteric surfactant compound of formula (I).
CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the gomeric compounds are conjugated to N-Acetylgalactosamine or to N-Acetylgalactosamine analogues.
CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the gomeric compounds are conjugated to N-Acetylgalactosamine or to N-Acetylgalactosamine analogues.
Glycosylated antitumor ether lipids as novel cancer stem cell cytotoxic agents
Glycosylated antitumor ether lipids (GAELs) are effective cytotoxic agents against cancer stem cells. Furthermore, combining GAELs which kill cells by a caspase-independent pathway with agents that kill cells by apoptosis will lead to elimination of the differentiated tumor cells and the undifferentiated cancer stem cells leading to an elimination of the tumor and preventing recurrence.
Glycosylated antitumor ether lipids as novel cancer stem cell cytotoxic agents
Glycosylated antitumor ether lipids (GAELs) are effective cytotoxic agents against cancer stem cells. Furthermore, combining GAELs which kill cells by a caspase-independent pathway with agents that kill cells by apoptosis will lead to elimination of the differentiated tumor cells and the undifferentiated cancer stem cells leading to an elimination of the tumor and preventing recurrence.
Sphingoglycolipid analogues
The invention relates to sphingoglycolipid analogues which are useful in treating or preventing diseases and conditions such as those relating to infection, atopic disorders, autoimmune diseases or cancer.
Sphingoglycolipid analogues
The invention relates to sphingoglycolipid analogues which are useful in treating or preventing diseases and conditions such as those relating to infection, atopic disorders, autoimmune diseases or cancer.
CARBOHYDRATE-BASED SURFACTANTS
The present invention provides carbohydrate-based surfactants and methods for producing the same. Methods for producing carbohydrate-based surfactants include using a glycosylation promoter to link a carbohydrate or its derivative to a hydrophobic compound.
CARBOHYDRATE-BASED SURFACTANTS
The present invention provides carbohydrate-based surfactants and methods for producing the same. Methods for producing carbohydrate-based surfactants include using a glycosylation promoter to link a carbohydrate or its derivative to a hydrophobic compound.